SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-20-003479
Filing Date
2020-06-22
Accepted
2020-06-22 11:53:32
Documents
68
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nbio_10k.htm 10-K 584621
2 CERTIFICATION nbio_ex311.htm EX-31.1 10112
3 CERTIFICATION nbio_ex312.htm EX-31.2 10081
4 CERTIFICATION nbio_ex321.htm EX-32.1 3952
5 CERTIFICATION nbio_ex322.htm EX-32.2 3900
12 nbio_10kimg2.jpg GRAPHIC 2883
13 nbio_10kimg3.jpg GRAPHIC 5592
  Complete submission text file 0001477932-20-003479.txt   3017314

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20200331.xml EX-101.INS 384600
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20200331.xsd EX-101.SCH 54571
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20200331_lab.xml EX-101.LAB 265564
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20200331_cal.xml EX-101.CAL 38845
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20200331_pre.xml EX-101.PRE 250054
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20200331_def.xml EX-101.DEF 143387
Mailing Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121
Business Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55299 | Film No.: 20977848
SIC: 2834 Pharmaceutical Preparations